Vivoryon

Vivoryon Therapeutics N.V. Gives Replace on Rising Physique of Proof Validating Glutaminyl Cyclases as Promising Targets in DKD at World Congress of Nephrology
Company Announcement

Vivoryon Therapeutics N.V. Gives Replace on Rising Physique of Proof Validating Glutaminyl Cyclases as Promising Targets in DKD at World Congress of Nephrology